5th Jan 2010 16:31
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2009, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £13.25 per Ordinary share and $42.40 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2009 to 31 December 2009:
|
Non Executive Director |
Ordinary Shares |
American Depository Shares (ADSs) |
|
Sir Christopher Gent |
2,547.17 |
|
|
Prof. Sir Roy Anderson |
636.79 |
|
|
Dr Stephanie Burns |
181.25 |
|
|
Mr Lawrence Culp |
181.25 |
|
|
Sir Crispin Davis |
2,358.49 |
|
|
Sir Deryck Maughan |
181.25 |
|
|
Mr James Murdoch |
495.28 |
|
|
Dr Daniel Podolsky |
253.76 |
|
|
Mr Tom de Swaan |
872.64 |
|
|
Sir Robert Wilson |
636.79 |
The Company and the Non-Executive Directors were informed of these allocations on 4 January 2010.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
5 January 2010
Related Shares:
Glaxosmithkline